Robin Wood

Q: What Schools Are Affiliated With Robin Wood

Robin Wood is affiliated with the following schools: University of California, Berkeley, University of Cape Town, University of Bordeaux, Stanford University

Robin Wood's AcademicInfluence.com Rankings

Robin Wood

Computer Science

#5069

World Rank

#5355

Historical Rank

Computational Linguistics

#618

World Rank

#630

Historical Rank

Machine Learning

#1201

World Rank

#1221

Historical Rank

Artificial Intelligence

#1433

World Rank

#1462

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Robin Wood's Degrees

PhD Computer Science Stanford University
Masters Artificial Intelligence University of California, Berkeley
Bachelors Computer Science University of California, Berkeley

Similar Degrees You Can Earn

Why Is Robin Wood Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Robin Wood's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection. (2015) (2235)
Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries (2006) (1171)
Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa (2008) (714)
Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study (2002) (617)
Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design (2005) (410)
Adherence is not a barrier to successful antiretroviral therapy in South Africa (2003) (406)
Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study. (2008) (401)
Life Expectancies of South African Adults Starting Antiretroviral Treatment: Collaborative Analysis of Cohort Studies (2013) (393)
Development of a Standardized Screening Rule for Tuberculosis in People Living with HIV in Resource-Constrained Settings: Individual Participant Data Meta-analysis of Observational Studies (2011) (391)
Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control (2006) (388)
Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohort (2005) (382)
Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa (2007) (352)
Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa (2009) (319)
Screening for cryptococcal antigenemia in patients accessing an antiretroviral treatment program in South Africa. (2009) (303)
Screening for HIV-Associated Tuberculosis and Rifampicin Resistance before Antiretroviral Therapy Using the Xpert MTB/RIF Assay: A Prospective Study (2011) (301)
Diagnostic accuracy of a low-cost, urine antigen, point-of-care screening assay for HIV-associated pulmonary tuberculosis before antiretroviral therapy: a descriptive study (2012) (300)
Determinants of Mortality in a Combined Cohort of 501 Patients With HIV-Associated Cryptococcal Meningitis: Implications for Improving Outcomes (2013) (297)
Nevirapine and Efavirenz Elicit Different Changes in Lipid Profiles in Antiretroviral- Therapy-Naive Patients Infected with HIV-1 (2004) (282)
Fungal burden, early fungicidal activity, and outcome in cryptococcal meningitis in antiretroviral-naive or antiretroviral-experienced patients treated with amphotericin B or fluconazole. (2007) (275)
Undiagnosed tuberculosis in a community with high HIV prevalence: implications for tuberculosis control. (2007) (262)
Nurse versus doctor management of HIV-infected patients receiving antiretroviral therapy (CIPRA-SA): a randomised non-inferiority trial (2010) (260)
Impact of HIV infection on the epidemiology of tuberculosis in a peri-urban community in South Africa: the need for age-specific interventions. (2006) (254)
Determinants of mortality and nondeath losses from an antiretroviral treatment service in South Africa: implications for program evaluation. (2006) (252)
Temporal changes in programme outcomes among adult patients initiating antiretroviral therapy across South Africa, 2002–2007 (2010) (251)
Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes (2010) (229)
Gender Differences in Survival among Adult Patients Starting Antiretroviral Therapy in South Africa: A Multicentre Cohort Study (2012) (229)
SOLO: 48-week efficacy and safety comparison of once-daily fosamprenavir /ritonavir versus twice-daily nelfinavir in naive HIV-1-infected patients (2004) (222)
AIDS among older children and adolescents in Southern Africa: projecting the time course and magnitude of the epidemic (2009) (220)
Immune reconstitution and "unmasking" of tuberculosis during antiretroviral therapy. (2008) (212)
Tuberculosis Incidence Rates during 8 Years of Follow-Up of an Antiretroviral Treatment Cohort in South Africa: Comparison with Rates in the Community (2012) (204)
Independent association between rate of clearance of infection and clinical outcome of HIV-associated cryptococcal meningitis: analysis of a combined cohort of 262 patients. (2009) (203)
Adjunctive interferon-&ggr; immunotherapy for the treatment of HIV-associated cryptococcal meningitis: a randomized controlled trial (2012) (201)
Urine lipoarabinomannan assay for tuberculosis screening before antiretroviral therapy diagnostic yield and association with immune reconstitution disease (2009) (197)
Long-term immunologic response to antiretroviral therapy in low-income countries: a collaborative analysis of prospective studies (2008) (194)
CD4 Decline and Incidence of Opportunistic Infections in Cape Town, South Africa: Implications for Prophylaxis and Treatment (2006) (193)
Rapid scale-up of a community-based HIV treatment service: programme performance over 3 consecutive years in Guguletu, South Africa. (2006) (189)
High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV-infected patients: a randomized trial. (2008) (185)
Antiretrovirals and isoniazid preventive therapy in the prevention of HIV-associated tuberculosis in settings with limited health-care resources. (2010) (179)
Relationship of cerebrospinal fluid pressure, fungal burden and outcome in patients with cryptococcal meningitis undergoing serial lumbar punctures (2009) (178)
Immune Reconstitution Inflammatory Syndrome in HIV-Associated Cryptococcal Meningitis: A Prospective Study (2009) (172)
An association between HIV‐1 subtypes and mode of transmission in Cape Town, South Africa (1997) (172)
How effectively does HAART restore immune responses to Mycobacterium tuberculosis? Implications for tuberculosis control (2005) (171)
Conservation of First-Line Antiretroviral Treatment Regimen where Therapeutic Options are Limited (2007) (168)
Association between tuberculosis and HIV disease progression in a high tuberculosis prevalence area. (2001) (167)
Substitutions due to antiretroviral toxicity or contraindication in the first 3 years of antiretroviral therapy in a large South African cohort. (2007) (164)
Switching to second-line antiretroviral therapy in resource-limited settings: comparison of programmes with and without viral load monitoring (2009) (163)
Linkage to HIV Care and Antiretroviral Therapy in Cape Town, South Africa (2010) (160)
Association of anal dysplasia and human papillomavirus with immunosuppression and HIV infection among homosexual men. (1993) (160)
When to start antiretroviral therapy in resource-limited settings. (2009) (157)
Cost-Effectiveness of Highly Active Antiretroviral Therapy in South Africa (2005) (154)
Changing patterns in HIV/AIDS stigma and uptake of voluntary counselling and testing services: The results of two consecutive community surveys conducted in the Western Cape, South Africa (2013) (153)
Changing prevalence of tuberculosis infection with increasing age in high-burden townships in South Africa. (2010) (151)
The transmission of Mycobacterium tuberculosis in high burden settings. (2016) (151)
Pulmonary tuberculosis in HIV infection: radiographic appearance is related to CD4+ T-lymphocyte count. (1995) (150)
Correcting Mortality for Loss to Follow-Up: A Nomogram Applied to Antiretroviral Treatment Programmes in Sub-Saharan Africa (2011) (150)
Immunodeficiency at the Start of Combination Antiretroviral Therapy in Low-, Middle-, and High-Income Countries (2013) (149)
Rates and Predictors of Failure of First-line Antiretroviral Therapy and Switch to Second-line ART in South Africa (2012) (148)
Public-Health and Individual Approaches to Antiretroviral Therapy: Township South Africa and Switzerland Compared (2008) (146)
Changing mortality risk associated with CD4 cell response to antiretroviral therapy in South Africa (2009) (140)
Yield of HIV-associated tuberculosis during intensified case finding in resource-limited settings: a systematic review and meta-analysis (2010) (139)
Changes in Programmatic Outcomes During 7 Years of Scale-up at a Community-Based Antiretroviral Treatment Service in South Africa (2011) (138)
CD4 cell count recovery among HIV-infected patients with very advanced immunodeficiency commencing antiretroviral treatment in sub-Saharan Africa (2006) (137)
Outcomes of the South African National Antiretroviral Treatment Programme for children: the IeDEA Southern Africa collaboration. (2009) (137)
Social mixing patterns within a South African township community: implications for respiratory disease transmission and control. (2011) (137)
Cryptococcocal immune reconstitution disease: a major cause of early mortality in a South African antiretroviral programme. (2005) (133)
The impact of gender and income on survival and retention in a South African antiretroviral therapy programme (2009) (132)
Mental health and sexual risk behaviours in a South African township: a community-based cross-sectional study. (2006) (128)
Tuberculosis in Antiretroviral Treatment Services in Resource-Limited Settings: Addressing the Challenges of Screening and Diagnosis (2011) (127)
Risk Factors for Developing Tuberculosis in HIV‐1‐Infected Adults From Communities With a Low or Very High Incidence of Tuberculosis (2000) (125)
Short-term risk of AIDS or death in people infected with HIV-1 before antiretroviral therapy in South Africa: a longitudinal study (2006) (125)
Comparison of the early fungicidal activity of high-dose fluconazole, voriconazole, and flucytosine as second-line drugs given in combination with amphotericin B for the treatment of HIV-associated cryptococcal meningitis. (2012) (123)
Virologic Failure and Second-Line Antiretroviral Therapy in Children in South Africa—The IeDEA Southern Africa Collaboration (2011) (123)
Antiretroviral Therapy for Control of the HIV-associated Tuberculosis Epidemic in Resource-Limited Settings (2009) (121)
Accelerated biological ageing in HIV-infected individuals in South Africa: a case–control study (2013) (121)
World-wide variation in HIV-1 phenotypic susceptibility in untreated individuals: biologically relevant values for resistance testing (2001) (120)
Cost Effectiveness of Cryptococcal Antigen Screening as a Strategy to Prevent HIV-Associated Cryptococcal Meningitis in South Africa (2013) (119)
Treatment outcomes in HIV-infected adolescents attending a community-based antiretroviral therapy clinic in South Africa (2012) (118)
A predominantly HIV type 1 subtype C-restricted epidemic in South African urban populations. (1999) (118)
When to Initiate Highly Active Antiretroviral Therapy in Sub-Saharan Africa? A South African Cost-Effectiveness Study (2006) (117)
Treatment Interruption in a Primary Care Antiretroviral Therapy Program in South Africa: Cohort Analysis of Trends and Risk Factors (2010) (116)
Mobile phone text messaging for promoting adherence to anti-tuberculosis treatment: a systematic review (2013) (115)
Antiretroviral therapy and the control of HIV-associated tuberculosis. Will ART do it? (2011) (114)
Early Mortality and Loss to Follow-up in HIV-Infected Children Starting Antiretroviral Therapy in Southern Africa (2010) (114)
Tuberculosis during the first year of antiretroviral therapy in a South African cohort using an intensive pretreatment screening strategy (2010) (112)
Strategies to reduce early morbidity and mortality in adults receiving antiretroviral therapy in resource-limited settings (2010) (112)
Long-Term Efficacy and Safety of Atazanavir With Stavudine and Lamivudine in Patients Previously Treated With Nelfinavir or Atazanavir (2004) (111)
The dynamics of QuantiFERON-TB gold in-tube conversion and reversion in a cohort of South African adolescents. (2015) (110)
Burden of New and Recurrent Tuberculosis in a Major South African City Stratified by Age and HIV-Status (2011) (110)
Serial QuantiFERON testing and tuberculosis disease risk among young children: an observational cohort study. (2017) (108)
Loss to follow-up and mortality among pregnant women referred to a community clinic for antiretroviral treatment (2008) (108)
Modeling the joint epidemics of TB and HIV in a South African township (2008) (107)
HIV type-1 clade C resistance genotypes in treatment-naive patients and after first virological failure in a large community antiretroviral therapy programme (2009) (107)
CD4 and total lymphocyte counts as predictors of HIV disease progression. (1996) (106)
Initiating co-trimoxazole prophylaxis in HIV-infected patients in Africa: an evaluation of the provisional WHO/UNAIDS recommendations (2001) (105)
Drivers of Tuberculosis Transmission (2017) (105)
Cryptococcal Antigen Screening in Patients Initiating ART in South Africa: A Prospective Cohort Study (2015) (105)
Chest radiograph reading and recording system: evaluation for tuberculosis screening in patients with advanced HIV. (2010) (105)
An Incentivized HIV Counseling and Testing Program Targeting Hard-to-Reach Unemployed Men in Cape Town, South Africa (2012) (104)
Modeling the role of public transportation in sustaining tuberculosis transmission in South Africa. (2013) (103)
Linkage to HIV Care From a Mobile Testing Unit in South Africa by Different CD4 Count Strata (2011) (101)
Scaling Up the 2010 World Health Organization HIV Treatment Guidelines in Resource-Limited Settings: A Model-Based Analysis (2010) (100)
Delayed switch of antiretroviral therapy after virologic failure associated with elevated mortality among HIV-infected adults in Africa (2014) (99)
Initiating highly active antiretroviral therapy in sub-Saharan Africa: an assessment of the revised World Health Organization scaling-up guidelines (2004) (98)
Integrating social contact and environmental data in evaluating tuberculosis transmission in a South African township. (2014) (97)
Accuracy of WHO CD4 cell count criteria for virological failure of antiretroviral therapy (2009) (96)
Frailty in HIV-Infected Adults in South Africa (2013) (96)
The cost-effectiveness of pre-exposure prophylaxis for HIV infection in South African women. (2012) (96)
The impact of human immunodeficiency virus (HIV) infection on quality of life in a multiracial South African population (1996) (94)
Usefulness of total lymphocyte count in monitoring highly active antiretroviral therapy in resource-limited settings (2003) (94)
Transmission of tuberculosis in a South African community with a high prevalence of HIV infection. (2015) (93)
Mortality after failure of antiretroviral therapy in sub‐Saharan Africa (2010) (93)
Changing Concepts of “Latent Tuberculosis Infection” in Patients Living with HIV Infection (2010) (92)
Adjusting Mortality for Loss to Follow-Up: Analysis of Five ART Programmes in Sub-Saharan Africa (2010) (92)
Adolescent HIV prevalence, sexual risk, and willingness to participate in HIV vaccine trials. (2006) (88)
Toxicity of Amphotericin B Deoxycholate-Based Induction Therapy in Patients with HIV-Associated Cryptococcal Meningitis (2015) (88)
Tuberculosis control has failed in South Africa--time to reappraise strategy. (2011) (88)
Loss to follow-up in a community clinic in South Africa--roles of gender, pregnancy and CD4 count. (2011) (87)
Rates of tuberculosis transmission to children and adolescents in a community with a high prevalence of HIV infection among adults. (2008) (87)
The cost-effectiveness of routine tuberculosis screening with Xpert MTB/RIF prior to initiation of antiretroviral therapy: a model-based analysis (2012) (85)
Initiating patients on antiretroviral therapy at CD4 cell counts above 200 cells/μl is associated with improved treatment outcomes in South Africa (2010) (84)
Utility of CD4 cell counts for early prediction of virological failure during antiretroviral therapy in a resource-limited setting (2008) (84)
Characteristics and Early Outcomes of Patients With Xpert MTB/RIF-Negative Pulmonary Tuberculosis Diagnosed During Screening Before Antiretroviral Therapy (2012) (84)
Tuberculosis transmission to young children in a South African community: modeling household and community infection risks. (2010) (82)
A Randomized Controlled Trial of Real-Time Electronic Adherence Monitoring With Text Message Dosing Reminders in People Starting First-Line Antiretroviral Therapy (2015) (81)
Scaling up antiretroviral therapy in South Africa: the impact of speed on survival. (2008) (81)
Comparative effectiveness of HIV testing and treatment in highly endemic regions. (2010) (79)
Provision of Antiretroviral Therapy in South Africa: The Nuts and Bolts (2014) (76)
Utility of interferon-γ ELISPOT assay responses in highly tuberculosis-exposed patients with advanced HIV infection in South Africa (2007) (76)
Linkage to HIV, TB and Non-Communicable Disease Care from a Mobile Testing Unit in Cape Town, South Africa (2013) (74)
Oral mucosal lesions: association with the presence of antibodies to the human immunodeficiency virus. (1989) (72)
Lipoarabinomannan in urine during tuberculosis treatment: association with host and pathogen factors and mycobacteriuria (2012) (72)
Feasibility, Yield, and Cost of Active Tuberculosis Case Finding Linked to a Mobile HIV Service in Cape Town, South Africa: A Cross-sectional Study (2012) (72)
Antiretroviral therapy in a community clinic--early lessons from a pilot project. (2003) (71)
Force of tuberculosis infection among adolescents in a high HIV and TB prevalence community: a cross-sectional observation study (2011) (71)
Screening for tuberculosis in adults with advanced HIV infection prior to preventive therapy. (2004) (70)
Virologic Failure of Protease Inhibitor-Based Second-Line Antiretroviral Therapy without Resistance in a Large HIV Treatment Program in South Africa (2012) (70)
Baseline HIV-1 resistance, virological outcomes, and emergent resistance in the SECOND-LINE trial: an exploratory analysis. (2015) (70)
Efficacy and Safety of Maraviroc Versus Efavirenz, Both With Zidovudine/Lamivudine: 96-Week Results From the MERIT Study (2010) (69)
Sexual risk behaviours and HIV-1 prevalence among urban men who have sex with men in Cape Town, South Africa. (2010) (69)
Clinical significance of lipoarabinomannan detection in urine using a low-cost point-of-care diagnostic assay for HIV-associated tuberculosis (2012) (68)
Association of human immunodeficiency virus and anal human papillomavirus infection among homosexual men. (1992) (67)
Cost-effectiveness of HIV treatment as prevention in serodiscordant couples. (2013) (65)
The Clinical Impact and Cost-Effectiveness of Routine, Voluntary HIV Screening in South Africa (2011) (65)
Earlier HIV diagnosis--are mobile services the answer? (2010) (64)
Antiretroviral program associated with reduction in untreated prevalent tuberculosis in a South African township. (2010) (64)
Antiretroviral roll-out, antifungal roll-back: access to treatment for cryptococcal meningitis. (2005) (64)
HIV-1 subtypes in different risk groups in South Africa (1995) (64)
Monitoring the South African National Antiretroviral Treatment Programme, 2003-2007: the IeDEA Southern Africa collaboration. (2009) (64)
Prevalent and Incident Tuberculosis Are Independent Risk Factors for Mortality among Patients Accessing Antiretroviral Therapy in South Africa (2013) (63)
Tuberculosis in a South African prison - a transmission modelling analysis. (2011) (62)
Antiretroviral Therapy and TB Notification Rates in a High HIV Prevalence South African Community (2011) (62)
Shared Air: A Renewed Focus on Ventilation for the Prevention of Tuberculosis Transmission (2014) (62)
RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response (2020) (61)
HIV Testing Rates and Outcomes in a South African Community, 2001-2006: Implications for Expanded Screening Policies (2009) (61)
Projecting the benefits of antiretroviral therapy for HIV prevention: the impact of population mobility and linkage to care. (2012) (61)
Molecular epidemiology of Mycobacterium tuberculosis in a South African community with high HIV prevalence. (2009) (61)
Brief report: methods for collecting sexual behaviour information from South African adolescents--a comparison of paper versus personal digital assistant questionnaires. (2007) (61)
Early Outcomes and the Virological Effect of Delayed Treatment Switching to Second-Line Therapy in An Antiretroviral Roll-Out Programme in South Africa (2011) (60)
Mobile HIV Screening in Cape Town, South Africa: Clinical Impact, Cost and Cost-Effectiveness (2014) (60)
The Clinical and Economic Impact of Point-of-Care CD4 Testing in Mozambique and Other Resource-Limited Settings: A Cost-Effectiveness Analysis (2014) (58)
High Diagnostic Yield of Tuberculosis From Screening Urine Samples From HIV-Infected Patients With Advanced Immunodeficiency Using The Xpert MTB/RIF Assay (2012) (58)
Diagnosing HIV-associated tuberculosis: reducing costs and diagnostic delay. (2000) (58)
Diagnostic and prognostic value of serum C-reactive protein for screening for HIV-associated tuberculosis. (2013) (58)
High Prevalence of Self-Reported Undiagnosed HIV despite High Coverage of HIV Testing: A Cross-Sectional Population Based Sero-Survey in South Africa (2011) (57)
Optimum time to start antiretroviral therapy during HIV-associated opportunistic infections (2011) (56)
HIV-associated tuberculosis: relationship between disease severity and the sensitivity of new sputum-based and urine-based diagnostic assays (2013) (55)
Indoor Social Networks in a South African Township: Potential Contribution of Location to Tuberculosis Transmission (2012) (55)
Reducing deaths from tuberculosis in antiretroviral treatment programmes in sub-Saharan Africa (2012) (55)
Cryptococcal Antigen Screening and Preemptive Therapy in Patients Initiating Antiretroviral Therapy in Resource-Limited Settings (2012) (55)
Effect of immediate initiation of antiretroviral therapy on risk of severe bacterial infections in HIV-positive people with CD4 cell counts of more than 500 cells per μL: secondary outcome results from a randomised controlled trial (2017) (55)
Modelling the risk of airborne infectious disease using exhaled air. (2015) (55)
Comparison of six methods to estimate adherence in an ART-naïve cohort in a resource-poor setting: which best predicts virological and resistance outcomes? (2017) (54)
Risk factors for poor virological outcome at 12 months in a workplace-based antiretroviral therapy programme in South Africa: A cohort study (2008) (54)
Management of HIV-associated tuberculosis in resource-limited settings: a state-of-the-art review (2013) (54)
The Evolving Cost of HIV in South Africa: Changes in Health Care Cost With Duration on Antiretroviral Therapy for Public Sector Patients (2007) (53)
Childhood tuberculosis infection and disease: a spatial and temporal transmission analysis in a South African township. (2009) (52)
Cost-effectiveness of World Health Organization 2010 Guidelines for Prevention of Mother-to-Child HIV Transmission in Zimbabwe (2012) (52)
The predictive value of current haemoglobin levels for incident tuberculosis and/or mortality during long-term antiretroviral therapy in South Africa: a cohort study (2015) (52)
Delays in starting antiretroviral therapy in patients with HIV-associated tuberculosis accessing non-integrated clinical services in a South African township (2011) (51)
The changing natural history of tuberculosis and HIV coinfection in an urban area of hyperendemicity. (2010) (51)
Establishing a workplace antiretroviral therapy programme in South Africa (2007) (51)
Detection of Mycobacterium tuberculosis bacilli in bio-aerosols from untreated TB patients. (2017) (50)
Incidence of tuberculosis during highly active antiretroviral therapy in high-income and low-income countries. (2005) (50)
Predictive Value of Anemia for Tuberculosis in HIV-Infected Patients in Sub-Saharan Africa: An Indication for Routine Microbiological Investigation Using New Rapid Assays (2014) (50)
Is cough really necessary for TB transmission? (2019) (50)
Six-Week Randomized Controlled Trial To Compare the Tolerabilities, Pharmacokinetics, and Antiviral Activities of GW433908 and Amprenavir in Human Immunodeficiency Virus Type 1-Infected Patients (2004) (49)
Cost-effectiveness of point-of-care viral load monitoring of antiretroviral therapy in resource-limited settings: mathematical modelling study (2013) (48)
Community Viral Load and CD4 Count Distribution Among People Living With HIV in a South African Township: Implications for Treatment as Prevention (2013) (48)
Decreasing household contribution to TB transmission with age: a retrospective geographic analysis of young people in a South African township (2014) (48)
Twelve-year mortality in adults initiating antiretroviral therapy in South Africa (2017) (48)
Not All Are Lost: Interrupted Laboratory Monitoring, Early Death, and Loss to Follow-Up (LTFU) in a Large South African Treatment Program (2012) (47)
Risk factors for developing tuberculosis in HIV-1-infected adults from communities with a low or very high incidence of tuberculosis. (2000) (47)
Treatment as prevention: preparing the way (2011) (47)
Resolution of anaemia in a cohort of HIV-infected patients with a high prevalence and incidence of tuberculosis receiving antiretroviral therapy in South Africa (2014) (45)
Mother-to-child transmission of HIV in a community-based antiretroviral clinic in South Africa. (2010) (45)
Mortality Associated With Discordant Responses to Antiretroviral Therapy in Resource-Constrained Settings (2010) (44)
Adolescent and adult participation in an HIV vaccine trial preparedness cohort in South Africa. (2008) (44)
Impact of human immunodeficiency virus and CD4 count on tuberculosis diagnosis: analysis of city-wide data from Cape Town, South Africa. (2013) (44)
Relationship Between Blood Concentrations of Hepcidin and Anemia Severity, Mycobacterial Burden, and Mortality Among Patients With HIV-Associated Tuberculosis (2015) (44)
Quantification of Shared Air: A Social and Environmental Determinant of Airborne Disease Transmission (2014) (44)
The Survival Benefits of Antiretroviral Therapy in South Africa (2013) (43)
Quality of life and the impact of drug toxicities in a South African community-based antiretroviral programme (2009) (43)
Pulmonary effects of immediate versus deferred antiretroviral therapy in HIV-positive individuals: a nested substudy within the multicentre, international, randomised, controlled Strategic Timing of Antiretroviral Treatment (START) trial. (2016) (42)
Tuberculosis in HIV programmes in lower-income countries: practices and risk factors. (2011) (40)
Efficacy and tolerability of 10-day monotherapy with apricitabine in antiretroviral-naive, HIV-infected patients (2006) (40)
Anaemia in patients with HIV-associated TB: relative contributions of anaemia of chronic disease and iron deficiency (2016) (40)
A Century of Tuberculosis Epidemiology in the Northern and Southern Hemisphere: The Differential Impact of Control Interventions (2015) (40)
Rates of Switching Antiretroviral Drugs in a Primary Care Service in South Africa before and after Introduction of Tenofovir (2013) (39)
Where do HIV-infected adolescents go after transfer? – Tracking transition/transfer of HIV-infected adolescents using linkage of cohort data to a health information system platform (2017) (38)
Potential Clinical and Economic Value of Long-Acting Preexposure Prophylaxis for South African Women at High-Risk for HIV Infection (2015) (38)
Viral load monitoring of antiretroviral therapy, cohort viral load and HIV transmission in Southern Africa: a mathematical modelling analysis (2012) (38)
The Anticipated Clinical and Economic Effects of 909090 in South Africa (2016) (38)
Intergroup comparisons of oral lesions in HIV-positive South Africans. (1997) (37)
A trial of mass isoniazid preventive therapy for tuberculosis control. (2014) (37)
Cryptococcal antigen screening for patients initiating antiretroviral therapy: time for action. (2010) (37)
Temporal Trends in the Characteristics of Children at Antiretroviral Therapy Initiation in Southern Africa: The IeDEA-SA Collaboration (2013) (37)
Location of Xpert® MTB/RIF in centralised laboratories in South Africa undermines potential impact. (2012) (37)
Real-Time Investigation of Tuberculosis Transmission: Developing the Respiratory Aerosol Sampling Chamber (RASC) (2016) (37)
Efavirenz and Rifampicin in the South African Context: Is There a Need to Dose-Increase Efavirenz with Concurrent Rifampicin Therapy? (2011) (37)
The clinical and economic impact of genotype testing at first-line antiretroviral therapy failure for HIV-infected patients in South Africa. (2013) (37)
Independent epidemics of heterosexual and homosexual HIV infection in South Africa--survival differences. (1997) (37)
Healthcare utilization of patients accessing an African national treatment program (2007) (36)
Frequent emergence of N348I in HIV-1 subtype C reverse transcriptase with failure of initial therapy reduces susceptibility to reverse-transcriptase inhibitors. (2012) (35)
Prognostic Value of a Quantitative Analysis of Lipoarabinomannan in Urine from Patients with HIV-Associated Tuberculosis (2014) (35)
Plasma levels of soluble urokinase-type plasminogen activator receptor (suPAR) and early mortality risk among patients enrolling for antiretroviral treatment in South Africa (2007) (35)
Tuberculosis in Cape Town: An age-structured transmission model. (2016) (35)
Genotype assays and third-line ART in resource-limited settings: a simulation and cost-effectiveness analysis of a planned clinical trial (2012) (35)
Improving HIV testing amongst adolescents through an integrated Youth Centre rewards program: Insights from South Africa (2014) (35)
Atazanavir: its role in HIV treatment (2008) (34)
Incentivized recruitment of a population sample to a mobile HIV testing service increases the yield of newly diagnosed cases, including those in need of antiretroviral therapy (2012) (34)
Prednisolone does not prevent hypersensitivity reactions in antiretroviral drug regimens containing abacavir with or without nevirapine (2001) (34)
Low Prevalence of Hepatitis C Virus Antibody in Men Who Have Sex with Men Who Do Not Inject Drugs (2007) (34)
CD4(+) T cell count decreases by ethnicity among untreated patients with HIV infection in South Africa and Switzerland. (2009) (34)
A survey of paediatric HIV programmatic and clinical management practices in Asia and sub-Saharan Africa—the International epidemiologic Databases to Evaluate AIDS (IeDEA) (2013) (34)
Tuberculosis should not be considered an AIDS-defining illness in areas with a high tuberculosis prevalence. (2002) (33)
Virologic Response in Children Treated With Abacavir-compared With Stavudine-based Antiretroviral Treatment: A South African Multi-Cohort Analysis (2014) (33)
Cost-effectiveness of public health strategies for COVID-19 epidemic control in South Africa: a microsimulation modelling study (2020) (33)
Computational models can predict response to HIV therapy without a genotype and may reduce treatment failure in different resource-limited settings. (2013) (33)
Comparison of Kaposi Sarcoma Risk in Human Immunodeficiency Virus-Positive Adults Across 5 Continents: A Multiregional Multicohort Study (2017) (33)
Location of Xpert® MTB/RIF in centralised laboratories in South Africa undermines potential impact [Correspondence]. (2012) (33)
The impact of HIV status and antiretroviral treatment on TB treatment outcomes of new tuberculosis patients attending co-located TB and ART services in South Africa: a retrospective cohort study (2015) (32)
Design and Evaluation of a Drama-Based Intervention to Promote Voluntary Counseling and HIV Testing in a South African Community (2006) (32)
Why START? Reflections that led to the conduct of this large long‐term strategic HIV trial (2015) (32)
Randomised controlled trial of isoniazid preventive therapy in South African adults with advanced HIV disease. (2007) (32)
Provider-initiated HIV testing increases access of patients with HIV-associated tuberculosis to antiretroviral treatment. (2011) (32)
Monitoring of Antiretroviral Therapy and Mortality in HIV Programmes in Malawi, South Africa and Zambia: Mathematical Modelling Study (2013) (32)
Risks and Benefits of Dolutegravir- and Efavirenz-Based Strategies for South African Women With HIV of Child-Bearing Potential (2019) (32)
Progression of subclinical culture-positive tuberculosis to symptomatic disease in HIV-infected individuals. (2011) (32)
Outcomes of Infants Starting Antiretroviral Therapy in Southern Africa, 2004–2012 (2015) (32)
Cost-effectiveness of public health strategies for COVID-19 epidemic control in South Africa: a microsimulation modelling study (2020) (31)
Low acceptability of medical male circumcision as an HIV/AIDS prevention intervention within a South African community that practises traditional circumcision. (2012) (31)
A comparison of death recording by health centres and civil registration in South Africans receiving antiretroviral treatment (2015) (31)
When to Start Antiretroviral Therapy in Children Aged 2–5 Years: A Collaborative Causal Modelling Analysis of Cohort Studies from Southern Africa (2013) (31)
Age in antiretroviral therapy programmes in South Africa: a retrospective, multicentre, observational cohort study. (2015) (31)
Time to Initiation of Antiretroviral Therapy Among Patients With HIV-Associated Tuberculosis in Cape Town, South Africa (2011) (31)
Low Rates of Nucleoside Reverse Transcriptase Inhibitor Resistance in a Well-Monitored Cohort in South Africa on Antiretroviral Therapy (2011) (30)
Long-term (120-Week) antiviral efficacy and tolerability of fosamprenavir/ritonavir once daily in therapy-naive patients with HIV-1 infection: an uncontrolled, open-label, single-arm follow-on study. (2006) (30)
Efficacy of antiretroviral therapy in resource-poor settings: are outcomes comparable to those in the developed world? (2005) (30)
Advances in the understanding of Mycobacterium tuberculosis transmission in HIV-endemic settings. (2019) (29)
Testing but not treating: missed opportunities and lost lives in the South African antiretroviral therapy programme. (2010) (29)
Exploring the costs of a limited public sector antiretroviral treatment programme in South Africa. (2002) (29)
Mobile phone text messaging for promoting adherence to anti-tuberculosis treatment: a systematic review protocol (2013) (29)
Community health care workers in South Africa are at increased risk for tuberculosis. (2010) (28)
The impact of the roll-out of rapid molecular diagnostic testing for tuberculosis on empirical treatment in Cape Town, South Africa (2017) (28)
Cost-effectiveness of urine-based tuberculosis screening in hospitalised patients with HIV in Africa: a microsimulation modelling study. (2019) (28)
Blood Neutrophil Counts in HIV-Infected Patients with Pulmonary Tuberculosis: Association with Sputum Mycobacterial Load (2013) (28)
Retreatment tuberculosis in a South African community: the role of re-infection, HIV and antiretroviral treatment. (2012) (28)
When should antiretroviral treatment be started in patients with HIV-associated tuberculosis in South Africa? (2007) (28)
Tuberculosis and the risk of opportunistic infections and cancers in HIV‐infected patients starting ART in Southern Africa (2013) (27)
Identification of losses to follow-up in a community-based antiretroviral therapy clinic in South Africa using a computerized pharmacy tracking system (2010) (27)
Is HIV-associated tuberculosis a risk factor for the development of cryptococcal disease? (2010) (27)
Accuracy of immunological criteria for identifying virological failure in children on antiretroviral therapy – The IeDEA Southern Africa Collaboration (2011) (27)
CD4 Count Slope and Mortality in HIV-Infected Patients on Antiretroviral Therapy: Multicohort Analysis From South Africa (2013) (27)
Mapping sites of high TB transmission risk: Integrating the shared air and social behaviour of TB cases and adolescents in a South African township (2017) (27)
Prognosis of Children With HIV-1 Infection Starting Antiretroviral Therapy in Southern Africa: A Collaborative Analysis of Treatment Programs (2014) (27)
How can earlier entry of patients into antiretroviral programs in low-income countries be promoted? (2006) (26)
Acute dichromate poisoning after use of traditional purgatives. A report of 7 cases. (1990) (26)
Safety, feasibility and efficacy of a rapid ART initiation in pregnancy pilot programme in Cape Town, South Africa. (2013) (26)
First-line antiretroviral therapy after single-dose nevirapine exposure in South Africa: a cost-effectiveness analysis of the OCTANE trial (2011) (26)
Colonic complications after toxic tribal enemas (1991) (25)
Hepatic involvement with tuberculosis-associated immune reconstitution disease. (2007) (25)
The epidemiology and clinical correlates of HIV-1 co-receptor tropism in non-subtype B infections from India, Uganda and South Africa (2012) (25)
Resistance in Pediatric Patients Experiencing Virologic Failure With First-line and Second-line Antiretroviral Therapy (2013) (25)
AIDS in Africa--survival according to AIDS-defining illness. (2001) (24)
Tuberculosis transmission in public locations in Tanzania: A novel approach to studying airborne disease transmission. (2017) (24)
The case for integrating tuberculosis and HIV treatment services in South Africa. (2007) (24)
Increasing Transfers-Out from an Antiretroviral Treatment Service in South Africa: Patient Characteristics and Rates of Virological Non-Suppression (2013) (24)
Routine cryptococcal antigen screening for HIV-infected patients with low CD4+ T-lymphocyte counts--time to implement in South Africa? (2011) (23)
HIV prevalence and determinants of loss-to-follow-up in adolescents and young adults with tuberculosis in Cape Town (2019) (23)
Corneal Endothelial Cells Provide Evidence of Accelerated Cellular Senescence Associated with HIV Infection: A Case-Control Study (2013) (23)
Inequality in outcomes for adolescents living with perinatally acquired HIV in sub‐Saharan Africa: a Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Cohort Collaboration analysis (2018) (23)
Temporal trends in TB notification rates during ART scale-up in Cape Town: an ecological analysis (2015) (22)
Monitoring of antiretroviral therapy in low-resource settings (2008) (22)
Antiretroviral Treatment as Prevention: Impact of the ‘Test and Treat’ Strategy on the Tuberculosis Epidemic (2011) (22)
Socio-behaviour challenges to phase III HIV vaccine trials in Sub-Saharan Africa. (2005) (22)
Tuberculosis control in South Africa--will HAART help? (2006) (21)
Detection of Mycobacterium tuberculosis bacilli in bio-aerosols from untreated TB patients (2018) (21)
Detection, survival and infectious potential of Mycobacterium tuberculosis in the environment: a review of the evidence and epidemiological implications (2019) (21)
Drivers of Seasonal Variation in Tuberculosis Incidence: Insights from a Systematic Review and Mathematical Model (2018) (21)
HIV and TB co-infection in the ART era: CD4 count distributions and TB case fatality in Cape Town (2018) (20)
Effect of mid-dose efavirenz concentrations and CYP2B6 genotype on viral suppression in patients on first-line antiretroviral therapy. (2016) (20)
Expanding Antiretroviral Options in Resource-Limited Settings-A Cost-Effectiveness Analysis (2009) (20)
Cost of a dedicated ART clinic. (2007) (20)
Blood safety--at what cost? (2006) (20)
Integration of TB and ART services fails to improve TB treatment outcomes: comparison of ART/TB primary healthcare services in Cape Town, South Africa. (2014) (20)
Human immunodeficiency virus-related abdominal pain in South Africa. Aetiology, diagnosis and survival. (1998) (19)
Restriction fragment length polymorphism analysis for rapid gag subtype determination of human immunodeficiency virus type 1 in South Africa. (1999) (19)
Optimum time to initiate antiretroviral therapy in patients with HIV-associated tuberculosis: there may be more than one right answer. (2007) (19)
Overview of extrapulmonary tuberculosis in adults and children (2009) (19)
Community perspectives on the ethical issues surrounding adolescent HIV vaccine trials in South Africa. (2008) (18)
Promoting retention in care: an effective model in an antiretroviral treatment service in South Africa. (2007) (18)
Capture and visualization of live Mycobacterium tuberculosis bacilli from tuberculosis patient bioaerosols. (2021) (18)
A qualitative assessment of perspectives on the inclusion of adolescents in HIV vaccine trials in South Africa (2010) (18)
Do Less Harm: Evaluating HIV Programmatic Alternatives in Response to Cutbacks in Foreign Aid (2017) (18)
Efficiency of Interventions in HIV Infection, 1994–2004 (2005) (17)
Cutaneous miliary tuberculosis in the AIDS era. (1997) (17)
Trends in CD4 and viral load testing 2005 to 2018: multi‐cohort study of people living with HIV in Southern Africa (2020) (17)
Poor Prognosis of HIV-Associated Tuberculous Meningitis Regardless of the Timing of Antiretroviral Therapy (2011) (17)
Impact of ART on TB Case Fatality Stratified by CD4 Count for HIV-Positive TB Patients in Cape Town, South Africa (2009–2011) (2014) (17)
Virological Breakthrough: A Risk Factor for Loss to Followup in a Large Community-Based Cohort on Antiretroviral Therapy (2011) (17)
Transmission elasticity in communities hyperendemic for tuberculosis. (2011) (17)
Social Contact Patterns and Implications for Infectious Disease Transmission: A Systematic Review and Meta-Analysis of Contact Surveys (2021) (17)
Diagnostic yield of tuberculosis using sputum induction in HIV-positive patients before antiretroviral therapy. (2012) (16)
Low Prevalence of Liver Disease but Regional Differences in HBV Treatment Characteristics Mark HIV/HBV Co-Infection in a South African HIV Clinical Trial (2013) (16)
Asking the right questions: developing evidence-based strategies for treating HIV in women and children (2011) (16)
Isoniazid preventive therapy for tuberculosis in South Africa: an assessment of the local evidence base. (2014) (16)
The impact of mass media interventions on tuberculosis awareness, health-seeking behaviour and health service utilisation: a systematic review protocol (2014) (16)
Time-dependent changes in HIV nucleoside analogue phosphorylation and the effect of hydroxyurea (2002) (16)
Viral load versus CD4+ monitoring and 5-year outcomes of antiretroviral therapy in HIV-positive children in Southern Africa: a cohort-based modelling study (2014) (16)
HIV/AIDS: a new South Africa takes responsibility. (2009) (16)
Risk factors for tuberculosis among HIV-infected patients receiving antiretroviral treatment. (2005) (16)
Predictors and prognostic value of oral hairy leukoplakia and oral candidiasis in South African HIV-infected patients. (2001) (15)
Point-of-Care CD4 Testing to Inform Selection of Antiretroviral Medications in South African Antenatal Clinics: A Cost-Effectiveness Analysis (2015) (15)
Should the CD4 threshold for starting ART be raised? (2009) (15)
The role of targeted viral load testing in diagnosing virological failure in children on antiretroviral therapy with immunological failure (2012) (15)
An update to the HIV-TRePS system: the development of new computational models that do not require a genotype to predict HIV treatment outcomes. (2014) (15)
Quality of life in HIV infection. (1996) (15)
High Rates of Recurrent Tuberculosis Disease: A Population-level Cohort Study (2020) (15)
Growth and Mortality Outcomes for Different Antiretroviral Therapy Initiation Criteria in Children Ages 1–5 Years: A Causal Modeling Analysis (2015) (15)
Point-of-care urine antigen screening tests for tuberculosis and cryptococcosis: potential for mortality reduction in antiretroviral treatment programs in Africa. (2012) (14)
Zidovudine impairs immunological recovery on first-line antiretroviral therapy: collaborative analysis of cohort studies in southern Africa (2013) (14)
Tenofovir in Second-Line ART in Zambia and South Africa: Collaborative Analysis of Cohort Studies (2012) (14)
Associations between baseline biomarkers and lung function in HIV-positive individuals (2019) (14)
Challenges of TB diagnosis and treatment in South Africa (2007) (13)
Can the Heterosexual HIV Epidemic be Eliminated in South Africa Using Combination Prevention? A Modeling Analysis. (2016) (13)
Antiretroviral treatment uptake in patients with HIV-associated TB attending co-located TB and ART services. (2012) (13)
The utility of pharmacy dispensing data for ART programme evaluation and early identification of patient loss to follow-up (2008) (13)
Usefulness of HIV-1 V3 serotyping in studying the HIV-1 epidemic in South Africa. (1998) (13)
Diagnostic yield of tuberculosis using sputum induction in HIV-positive patients before antiretroviral therapy [Short communication]. (2012) (13)
Has the phasing out of stavudine in accordance with changes in WHO guidelines led to a decrease in single-drug substitutions in first-line antiretroviral therapy for HIV in sub-Saharan Africa? (2017) (13)
Co-trimoxazole in HIV-1 infection (1999) (13)
Earlier Antiretroviral Therapy Initiation and Decreasing Mortality Among HIV-infected Infants Initiating Antiretroviral Therapy Within 3 Months of Age in South Africa, 2006–2017 (2019) (13)
Association Between Single-Nucleotide Polymorphisms in HLA Alleles and Human Immunodeficiency Virus Type 1 Viral Load in Demographically Diverse, Antiretroviral Therapy–Naive Participants From the Strategic Timing of AntiRetroviral Treatment Trial (2019) (13)
Simplifying HIV cohort monitoring--pharmacy stock records minimize resources necessary to determine retention in care. (2013) (13)
Tuberculosis and HIV infection [1] (1991) (12)
Detection of Tuberculosis by The Analysis of Exhaled Breath Particles with High-resolution Mass Spectrometry (2020) (12)
Special Report on the State of HIV/AIDS in South Africa (2010) (12)
Ocular parameters of biological ageing in HIV-infected individuals in South Africa: Relationship with chronological age and systemic biomarkers of ageing (2013) (12)
The Clinical and Economic Impact of Point-of-Care CD 4 Testing in Mozambique and Other Resource-Limited Settings : A Cost-Effectiveness Analysis (2014) (12)
CD 4 cell count recovery among HIV-infected patients with very advanced immunodeficiency commencing antiretroviral treatment in sub-Saharan Africa (2015) (12)
Aerosolization of Mycobacterium tuberculosis by Tidal Breathing (2020) (12)
Challenges facing lipoarabinomannan urine antigen tests for diagnosing HIV-associated tuberculosis (2012) (12)
Reducing CD4 Monitoring in Children on Antiretroviral Therapy With Virologic Suppression (2015) (12)
Pneumocystis carinii pneumonia in HIV-infected patients in Africa--an important pathogen? (2000) (11)
Clinical performance of an in-house real-time RT-PCR assay using a fluorogenic LUX primer for quantitation of human immunodeficiency virus type-1 (HIV-1). (2007) (11)
Evaluating a model for monitoring the virological efficacy of antiretroviral treatment in resource-limited settings. (2006) (11)
CD4+ T cell recovery during suppression of HIV replication: an international comparison of the immunological efficacy of antiretroviral therapy in North America, Asia and Africa (2015) (11)
The impact of delayed switch to second-line antiretroviral therapy on mortality, depending on failure time definition and CD4 count at failure (2019) (11)
An integrated community TB-HIV adherence model provides an alternative to DOT for tuberculosis patients in Cape Town. (2016) (11)
Cost-effectiveness of point-of-care viral load monitoring of ART in resource-limited settings: Mathematical modelling study (2016) (10)
An update to the HIV-TRePS system: the development and evaluation of new global and local computational models to predict HIV treatment outcomes, with or without a genotype. (2016) (10)
HIV infection is not associated with an increased rate of drug-resistant tuberculosis. (1997) (10)
Trends in CD4 and viral load testing 2005 to 2018: Multi-cohort study of people living with HIV in Southern Africa (2020) (10)
Temporal Association Between Incident Tuberculosis and Poor Virological Outcomes in a South African Antiretroviral Treatment Service (2013) (10)
Forced removals embodied as tuberculosis. (2016) (10)
Combined antiretroviral therapy. (1996) (10)
Substitutions Due to Antiretroviral Toxicity or Contraindication in the First 3 years of Antiretroviral Therapy in a Large South African Cohort (2007) (10)
Nevirapine toxicity--implications for management of South African patients. (2005) (10)
Implementation and Operational Research: Risk Charts to Guide Targeted HIV-1 Viral Load Monitoring of ART: Development and Validation in Patients From Resource-Limited Settings (2015) (10)
Is HIV/AIDS a primary‐care disease? Appropriate levels of outpatient care for patients with HIV/AIDS (1995) (10)
Temporal trends in the prevalence of Mycobacterium tuberculosis infection in South African adolescents. (2019) (10)
Evaluation of nevirapine and/or hydroxyurea with nucleoside reverse transcriptase inhibitors in treatment-naive HIV-1-infected subjects (2004) (9)
Environmental and social factors impacting on epidemic and endemic tuberculosis: a modelling analysis (2018) (9)
Tuberculous pleural effusions in HIV-positive patients. (1998) (9)
Cough-independent production of viable Mycobacterium tuberculosis in bioaerosol. (2020) (9)
Tuberculosis transmission from patients with smear-negative pulmonary tuberculosis in sub-Saharan Africa. (2009) (9)
Immune reconstitution inflammatory syndrome. (2010) (9)
Nurse management is not inferior to doctor management of antiretroviral patients: The CIPRA South Africa randomised trial (2011) (9)
The Impact of Delayed Switch to Second-Line Antiretroviral Therapy on Mortality, Depending on Deﬁnition of Failure Time and CD4 Count at Failure (2020) (9)
Bioaerosol sampling of patients with suspected pulmonary tuberculosis: a study protocol (2020) (9)
Detection and management of drug-resistant tuberculosis in HIV-infected patients in lower-income countries. (2014) (9)
Factors affecting tuberculosis strain success over 10 years in a high TB- and HIV-burdened community. (2014) (9)
Prognosis of HIV-1-infected Patients Starting ART in Sub-Saharan Africa: A Collaborative Analysis of Scale-up Programs (2010) (9)
A 42-week open-label study to assess the pharmacokinetics, antiretroviral activity, and safety of amprenavir or amprenavir plus ritonavir in combination with abacavir and lamivudine for treatment of HIV-infected patients. (2004) (9)
Assessing the impact of prevalent tuberculosis on mortality among antiretroviral treatment initiators: accurate tuberculosis diagnosis is essential. (2012) (9)
The epidemic of HIV-associated tuberculosis in sub-Saharan Africa: does this also impact non-HIV-infected individuals? (2006) (8)
Tuberculosis screening in patients starting antiretroviral therapy in sub-Saharan Africa: stretching diagnostics to the limits. (2011) (8)
Sexual risk factors associated with volunteering for HIV vaccine research in South Africa (2006) (8)
Sensitivity optimisation of tuberculosis bioaerosol sampling (2020) (8)
Adolescents and HIV Vaccine Trials (2005) (8)
Estimating age-mixing patterns relevant for the transmission of airborne infections (2019) (8)
On the relationship between age, annual rate of infection, and prevalence of mycobacterium tuberculosis in a South African township. (2009) (8)
The role of stavudine in the South African public sector antiretroviral programme : should the perfect be the enemy of the good? : public health (2006) (8)
TB and HIV co-infection: When to start antiretroviral therapy (2011) (8)
Editorial commentary: universal antiretroviral therapy for HIV infection? (2013) (8)
Tuberculosis screening among ambulatory people living with HIV: a systematic review and individual participant data meta-analysis (2021) (8)
GW420867X Administered to HIV-1-Infected Patients Alone and in Combination with Lamivudine and Zidovudine (2001) (8)
Seminal Mycobacterium Tuberculosis in vivo Transmission Studies: ReanalysisUsing Probabilistic Modelling (2016) (7)
Body composition and metabolic outcomes after 96 weeks of treatment with ritonavir-boosted lopinavir plus either nucleoside or nucleotide reverse transcriptase inhibitors or raltegravir in patients with HIV with virological failure of a standard first-line antiretroviral therapy regimen: a substudy (2017) (7)
The Hannan Crusaid Treatment Centre – early beginnings and lessons learnt (2014) (7)
GeneXpert TB 8: A point-of-care diagnostic pilot. (2014) (7)
The mass miniature chest radiography programme in Cape Town, South Africa, 1948 - 1994: The impact of active tuberculosis case finding. (2016) (7)
Decision maker priorities for providing antiretroviral therapy in HIV-infected South Africans: A qualitative assessment (2012) (7)
Reducing the burden of tuberculosis presenting during the initial months of antiretroviral therapy in resource-limited settings. (2010) (7)
Antiretroviral therapy in South Africa--can we do it? (2002) (7)
Total lymphocyte count as a surrogate for CD4+ lymphocyte count in African patients coinfected with HIV and tuberculosis. (1996) (7)
Concurrent drug therapy for tuberculosis and HIV infection in resource-limited settings: present status and future prospects (2007) (7)
Optimum time to start antiretroviral therapy in patients with HIV-associated tuberculosis: before or after tuberculosis diagnosis? (2011) (7)
Single nucleotide polymorphisms in HLA alleles are associated with HIV-1 viral load in demographically diverse, ART-naïve participants from the START trial. (2019) (7)
Short-course untargeted isoniazid preventive therapy in South Africa: time to rethink policy? (2012) (7)
Tuberculosis screening among HIV-positive inpatients: a systematic review and individual participant data meta-analysis (2022) (7)
The impact of antiretroviral treatment programs on tuberculosis notification rates. (2011) (7)
A review of the efficiency of interventions in HIV infection 1994-2003. (2005) (7)
Adherence to antiretroviral therapy--achievable in the South African context? (2001) (6)
Screening for active tuberculosis among patients accessing antiretroviral therapy in sub-Saharan Africa. (2009) (6)
Growth and Mortality Outcomes for Different Antiretroviral Therapy Initiation Criteria in Children aged 1–5 Years: A Causal Modelling Analysis (2017) (6)
When to start antiretroviral therapy in children with TB? (2010) (6)
Medication Side Effects and Retention in HIV Treatment: A Regression Discontinuity Study of Tenofovir Implementation in South Africa and Zambia (2018) (6)
Cost-effectiveness of a Novel Lipoarabinomannan Test for Tuberculosis in Patients With Human Immunodeficiency Virus (2020) (6)
Computational models as predictors of HIV treatment outcomes for the Phidisa cohort in South Africa (2016) (6)
Setting Performance Standards for a Cost-Effective Human Immunodeficiency Virus Cure Strategy in South Africa (2017) (6)
Frequent Emergence of N 348 I in HIV-1 Subtype C Reverse Transcriptase with Failure of Initial Therapy Reduces Susceptibility to Reverse-Transcriptase Inhibitors (2012) (6)
Survival of human immunodeficiency virus-infected persons with pulmonary tuberculosis. (1997) (6)
Community-based management of multidrug-resistant tuberculosis in South Africa. (2010) (6)
National adult antiretroviral therapy guidelines in South Africa: concordance with 2003 WHO guidelines? (2007) (6)
Impact of antituberculosis treatment on virological response to highly active antiretroviral therapy: implications for resource-limited settings? (2006) (6)
Seasonal drivers of tuberculosis: evidence from over 100 years of notifications in Cape Town. (2020) (6)
Prioritizing Healthcare Delivery in a Conflict Zone Comment on "TB/HIV Co-Infection Care in Conflict-Affected Settings: A Mapping of Health Facilities in the Goma Area, Democratic Republic of Congo". (2013) (6)
Mean CD4 cell count changes in patients failing a first-line antiretroviral therapy in resource-limited settings (2012) (5)
A pharmacy stock control management system to effectively monitor and manage patients on ART (2006) (5)
HIV-related tuberculosis. (1997) (5)
O113 HIV-1 clade C resistance genotypes after first virological failure in a large community ART programme (2008) (5)
2018 update to the HIV-TRePS system: the development of new computational models to predict HIV treatment outcomes, with or without a genotype, with enhanced usability for low-income settings (2018) (5)
Cost-effectiveness of public health strategies for COVID-19 epidemic control 1 in South Africa (2020) (5)
CD4 cell count distributions and HIV-associated mortality in Africa. (2007) (5)
Combining urine lipoarabinomannan with antibody detection as a simple non-sputum-based screening method for HIV-associated tuberculosis (2019) (5)
Is it time to change our HIV testing policy in health care facilities? (2006) (5)
10 – Clinical Features and Management of HIV/AIDS (2014) (5)
Benign symmetrical lipomatosis--a complication of excessive alcohol consumption. A case report. (1990) (5)
Antiretroviral therapy for control of the HIV-associated MDR and XDR tuberculosis epidemic in South Africa. (2010) (5)
The spectrum and prognosis of AIDS-defining illnesses in Cape Town (2005) (5)
Early antiretroviral therapy mortality in resource-limited settings: what can we do about it? (2007) (4)
Non-volatile organic compounds in exhaled breath particles correspond to active tuberculosis (2022) (4)
Prevalence of latent TB infection and TB disease among adolescents in high TB burden countries in Africa: a systematic review protocol (2017) (4)
An investigation into the statistical properties of TB episodes in a South African community with high HIV prevalence. (2011) (4)
CD41 T cell recovery during suppression of HIV replication: an international comparison of the immunological efficacy of antiretroviral therapy in North America, Asia and Africa. (2015) (4)
RISK6, a universal 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response (2019) (4)
Molecular Detection of Airborne Mycobacterium tuberculosis in South African High Schools. (2021) (4)
Oral abstracts of the 21st International AIDS Conference 18–22 July 2016, Durban, South Africa (2016) (4)
Social contact patterns and implications for infectious disease transmission: a systematic review and meta-analysis of contact surveys. (2021) (4)
Capture and visualization of live Mycobacterium tuberculosis bacilli from tuberculosis bioaerosols (2019) (4)
AIDS in Africa (1987) (4)
The natural history of HIV infection in Africa. (2006) (3)
Reducing Mortality Associated with Opportunistic Infections among Patients with Advanced HIV Infection in Sub-Saharan Africa: Reply to DiNubile (2009) (3)
Evolution of resistance in paediatric patients with failure on antiretroviral therapy (2012) (3)
Antiretroviral Treatment Cohort Analysis Using Time-Updated CD4 Counts: Assessment of Bias with Different Analytic Methods (2011) (3)
Resistance to first-line ART and a role for dolutegravir. (2017) (3)
Remote sensing of HIV care programmes using centrally collected laboratory results: can we monitor ART programme effectiveness? (2012) (3)
Regional changes in tuberculosis disease burden among adolescents in South Africa (2005–2015) (2020) (3)
HIV-RELATED TUBERCULOSIS. AUTHOR'S REPLY (1997) (3)
Are the effects of isoniazid preventive therapy and highly active antiretroviral therapy additive in preventing HIV-associated tuberculosis? (2009) (3)
CO-TRIMOXAZOLE IN HIV-1 INFECTION. AUTHORS' REPLY (1999) (3)
The value of point-of-Care CD4 and Laboratory viral Load in tailoring ART monitoring Strategies to resource limitations. (2017) (3)
What Should We Do When HIV-positive Children Fail First-line Combination Antiretroviral Therapy? A Comparison of 4 ART Management Strategies. (2019) (3)
Determine TB-LAM point-of-care tuberculosis assay predicts poor outcomes in outpatients during their first year of antiretroviral therapy in South Africa (2020) (3)
Novel approach to estimate tuberculosis transmission in primary care clinics in sub-Saharan Africa: protocol of a prospective study (2020) (3)
Should we be initiating antiretroviral therapy earlier? An argument in favour. (2005) (3)
Utility of CD 4 cell counts for early prediction of virological failure during antiretroviral therapy in a resource-limited setting (2008) (3)
Long-Term Safety Study of Fosamprenavir-Containing Regimens in HIV-1–Infected Patients (2013) (3)
Large Scale Implementation of Antiretroviral Therapy: Early Results from Faith-based Clinics in South Africa. (2007) (3)
Integrating the care of HIV and TB in developing countries (2007) (3)
Mycobacterium tuberculosis Transmission in High-Incidence Settings—New Paradigms and Insights (2022) (3)
What Should we do When HIV-Positive Children Fail First-Line Combination Antiretroviral Therapy? A Comparison of 4 ART Management Strategies. (2019) (2)
O124 Efavirenz and rifampicin in the South African context: is there a need to dose increase efavirenz with concurrent rifampicin therapy? (2008) (2)
Brief Report: Assessing the Association Between Changing NRTIs When Initiating Second-Line ART and Treatment Outcomes (2017) (2)
Urine antigen test for diagnosis of HIV-associated tuberculosis – Authors' reply (2012) (2)
Reply to Pasqualotto (2008) (2)
Does antiretroviral therapy have a role to play in the control of tuberculosis in South Africa? (2001) (2)
Country review: South Africa (2008) (2)
Effect of antiretroviral therapy care interruptions on mortality in children living with HIV (2022) (2)
Modelling response to antiretroviral therapy without a genotype as a clinical tool for resource-limited settings (2011) (2)
Impact of effective contact rate and post treatment immune status on population tuberculosis infection and disease using a mathematical model (2017) (2)
Timing of antiretroviral therapy for HIV-1-associated tuberculosis. (2012) (2)
Shortened Tuberculosis Treatment for People with HIV in South Africa: A Model-based Evaluation and Cost-effectiveness Analysis. (2020) (2)
The value of point-of-care CD4+ and laboratory viral load in tailoring antiretroviral therapy monitoring strategies to resource limitations. (2017) (2)
Do we need a national antiretroviral treatment register? (2003) (2)
Computational models that predict response to HIV therapy can reduce virological failure and therapy costs in resource‐limited settings (2012) (2)
Ultrasound for the diagnosis of HIV-associated tuberculosis. (2003) (2)
Reply to Theron et al (2012) (1)
Track C Epidemiology and Prevention Science (2012) (1)
Prevalence of gastrointestinal symptoms in HIV disease in South Africa (1995) (1)
HPTN 069/ACTG A5305: phase II study of maraviroc-containing regimens for HIV PrEP in US women; Postive impact of a randomized controlled trial of the Uthando Lwethu ("Our Love") intervention on rates of couples HIV testing in rural South Africa (2016) (1)
Predicting Virological Response to HIV Treatment Over Time: A Tool for Settings With Different Definitions of Virological Response (2019) (1)
New antiretrovirals: What is on the way? (2008) (1)
Reply to Ouattara et al.: past history of tuberculosis is not a risk factor for incident tuberculosis during antiretroviral treatment in South Africa. (2007) (1)
Derivation and external validation of a risk score for predicting HIV-associated tuberculosis to support case finding and preventive therapy scale-up: A cohort study (2021) (1)
In reply to 'C-reactive protein and tuberculosis screening: a new trick for an old dog?'. (2013) (1)
Environmental air sampling for detection and quantification of Mycobacterium tuberculosis in clinical settings: Proof of concept. (2022) (1)
O133 HIV/TB: when is it safe to start HAART? (2008) (1)
Characteristics of Xpert MTB/RIF-Negative Patients With Pulmonary Tuberculosis Reply (2012) (1)
Estimating Tuberculosis Transmission Risks in a Primary Care Clinic in South Africa: Modeling of Environmental and Clinical Data. (2022) (1)
Response to the communication of M Hosp et al. on low‐cost progression markers in HIV‐1 seropositive Zambians (2001) (1)
An epidemic uncurbed: tuberculosis in Cape Town, South Africa, 1910–2010 (2017) (1)
Are the effects of isoniazid preventive therapy and HAART additive in preventing of HIV-associated tuberculosis? (2013) (1)
The differential impact of HIV and antiretroviral therapy on gender‐specific tuberculosis rates (2019) (1)
96 – Tuberculosis in HIV (2017) (1)
O169 High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV: a randomised study (2007) (1)
Accurate prediction of response to HIV therapy without a genotype: a potential tool for therapy optimization in resource-limited settings (2013) (1)
Unrecognised Mycobacterium tuberculosis (2000) (1)
Response to "CD4 cell count natural history and informative censoring in sub-Saharan Africa". (2007) (1)
Antiretroviral Initiation at ≥800 CD4+ Cells/mm3 Associated With Lower Human Immunodeficiency Virus Reservoir Size (2022) (1)
New antiretroviral drugs: What\'s on the horizon in 2005? (2005) (1)
make up JUNE issue nicky (2005) (0)
Low cost prognostic indicators of HIV infection (2001) (0)
Author's manuscript (2014) (0)
Correction to: Bioaerosol sampling of patients with suspected pulmonary tuberculosis: a study protocol (2020) (0)
Early Mortality Among Patients with HIV-Associated Tuberculosis in Africa : Implications for the Time to Initiation of Antiretroviral Treatment (2007) (0)
A Causal Modeling Analysis (0)
HIV/AIDS in South Africa: Antiretroviral therapy (2010) (0)
HIV care and support at an HIV clinic in Cape Town. (1996) (0)
Prevalence of CCR5-tropic HIV-1 among treatment-experienced individuals in South Africa infected with Clade C virus (2008) (0)
Past history of tuberculosis is not a risk factor for incident tuberculosis during antiretroviral treatment in South Africa [letter] [reply] (2007) (0)
Abacavir safety and effectiveness in young infants with HIV in South African observational cohorts (2023) (0)
Optimum Time to Initiate Antiretroviral Therapy in Patients With HIV-Associated Tuberculosis: A Reply (2009) (0)
Steve Lawn (13 March 1966 - 23 September 2016) (2017) (0)
Shared locations of TB cases: places of acquisition or transmission of infection? (2015) (0)
RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response (2020) (0)
Erratum: Correction to: Bioaerosol sampling of patients with suspected pulmonary tuberculosis: a study protocol (BMC infectious diseases (2020) 20 1 (587)) (2020) (0)
Indoor Air Quality and Tuberculosis Risk in Two South African Schools (2020) (0)
Utility of patient retention for evaluation of antiretroviral treatment programs in sub-Saharan Africa (2008) (0)
Should we be initiating antiretroviral therapy earlier (2005) (0)
CUTANEOUS MILIARY TUBERCULOSIS IN THE AIDS ERA. AUTHORS' REPLY (1997) (0)
Reply to Yates et al (2014) (0)
Regression discontinuity analysis demonstrated varied effect of Treat-All on CD4 testing among Southern African countries. (2021) (0)
UvA-DARE ( Digital Academic Repository ) Nevirapine and Efavirenz Elicit Different Changes in Lipid Profiles in Antiretroviral-Therapy-Naive Patients Infected with HIV-1 (2017) (0)
Point-of-Care CD 4 Testing to Inform Selection of Antiretroviral Medications in South African Antenatal Clinics : A Cost-Effectiveness Analysis (2015) (0)
Tuberculosis of lymph nodes and the reticuloendothelial system in adults (2009) (0)
Following the HIV-1 trail--from source to South Africa. (1999) (0)
HIV and Tuberculosis Co-Infection (2008) (0)
Reply to Boyles: testing for lipoarabinomannan in patients with advanced immunodeficiency - much to gain and little to lose. (2012) (0)
Clinical and radiological features suggestive of disseminated tuberculosis in patients with HIV-related abdominal pain (1998) (0)
Abstract 124, 17th Conference on Retroviruses and Opportunistic Infections San Francisco, USA (2010) (0)
Quality of life of HIV-infected individuals in a community-based antiretroviral programme (2008) (0)
C O MMENT A R Y Open Access (2011) (0)
Neighbourhood risk factors of recurrent tuberculosis in Cape Town: a cohort study using geocoded notification data (2022) (0)
Changes in Tuberculosis Disease Burden Among South African Adolescents, 2005-2015 (2019) (0)
From despair to hope studies in HIV and tuberculosis 1992-2011 (2012) (0)
Detection of Tuberculosis by The Analysis of Exhaled Breath Particles with High-resolution Mass Spectrometry (2020) (0)
Massive hepatomegaly due to visceral leishmaniasis (2003) (0)
Diagnostic accuracy of WHO screening criteria to guide lateral-flow lipoarabinomannan testing among HIV-positive inpatients: a systematic review and individual participant data meta-analysis. (2022) (0)
Pneumoproteins and biomarkers of inflammation and coagulation do not predict rapid lung function decline in people living with HIV (2023) (0)
Pneumoproteins and biomarkers of inflammation and coagulation do not predict rapid lung function decline in people living with HIV (2023) (0)
P.454 Low prevalence of antibody to hepatitis C virus in men who have sex with men who do not report a history of injection drug use (2006) (0)
Chapter 93 – Tuberculosis in HIV (2010) (0)
Transmission Of Tuberculosis Among illicit drug use Linkages (TOTAL): A cross-sectional observational study protocol using respondent driven sampling (2022) (0)
Excessive weight gain following therapy for hyperthyroidism — a major problem (2003) (0)
National antiretroviral treatment register - a necessity? (2003) (0)
Changes in Tuberculosis Disease Burden Among South African Adolescents (2005-2015) (2019) (0)
The impact of a change in infant BCG vaccination policy on adolescent TB incidence rates: A South African population-level cohort study. (2021) (0)
New tricks for an old dog: opportunities for better tuberculosis control (2023) (0)
2021 update to HIV-TRePS: a highly flexible and accurate system for the prediction of treatment response from incomplete baseline information in different healthcare settings. (2021) (0)
Himmelfarb Health Sciences Library, Th e George Washington University (2014) (0)
Diagnostic Yield of Urine Lipoarabinomannan and Sputum Tuberculosis Tests in People Living with HIV: A Systematic Review and Meta-Analysis of Individual Participant Data (2022) (0)
Pulmonary Effects of Immediate Versus Deferred Antriretroviral Treatment Initiation: Final Follow-Up Results from the Randomized Strategic Timing of Antiretroviral Treatment (START) Pulmonary Substudy (2018) (0)
Virologic response to efavirenz-based first-line antiretroviral therapy in children with previous exposure to antiretrovirals to prevent mother-to-child transmission (2020) (0)
Factors Associated With and Characteristic of HIV/Tuberculosis Co-Infection: A Retrospective Analysis of SECOND-LINE Clinical Trial Participants (2021) (0)
Concurrent treatment of tuberculosis and HIV infection: current status and future prospects. (2007) (0)
Effect of Early Immunovirologic Discordant Responses on Mortality in Naïve HIV-1-infected Adults Initiating Treatment in Rsource-constrained Countries (2008) (0)
Design and Evaluation of a Drama-Based Intervention to Promote Voluntary Counseling and HIV Testing in a (2006) (0)
Delayed Switch of Antiretroviral Therapy Following Confirmed Virological Failure is Associated with Elevated Mortality among HIV-infected Adults in Africa. (2014) (0)
Virologic response of adolescents living with perinatally acquired HIV receiving antiretroviral therapy in the period of early adolescence (10–14 years) in South Africa (2021) (0)
The immune reconstitution inflammatory syndrome: a systematic review (2014) (0)
2021 update to HIV-TRePS: a highly flexible and accurate system for the prediction of treatment response from incomplete baseline information in different healthcare settings. (2021) (0)
Has the phasing out of stavudine in accordance with changes in WHO guidelines led to a decrease in single-drug substitutions in first-line antiretroviral therapy for HIV in sub-Saharan Africa? (2017) (0)
UvA-DARE ( Digital Academic Repository ) Nevirapine and Efavirenz Elicit Different Changes in Lipid Profiles in Antiretroviral-Therapy-Naive Patients Infected with HIV (2004) (0)
Estimating Cumulative Mortality of HIV-1 Infected Patients at 2 Years After Starting ART in Sub-Saharan Africa Using Methods for Modelling Missing Data to Account for Loss to Follow up: the IeDEA Prognostic Model (2008) (0)
Prioritizing Healthcare Delivery in a Conflict Zone; Comment on 'TB/HIV Co-Infection Care in Conflict-Affected Settings: A Mapping of Health Facilities in the Goma Area, Democratic Republic of Congo' (2013) (0)
Eleventh International Congress on Drug Therapy in HIV Infection (2012) (0)
TUPDC0103: Gonorrhea infections diagnosed among persons living with HIV: cross matching surveillance registries to identify potential opportunities for integrated partner services-New York City, Washington D.C., Miami/Dade County and Arizona (2012) (0)
Eleventh International Congress on Drug Therapy in HIV Infection (2012) (0)
Effect of HAART on TB in South Africa (2002) (0)
HIV-related tuberculosis [letter] (1997) (0)
Prevalence of tuberculosis infection among South African adolescents (2018) (0)
1284. Study of Single Nucleotide Polymorphisms Associated with HIV-1 Set-Point Viral Load in Antiretroviral Therapy-Naïve HIV-Positive Participants of the START Study (2018) (0)
Short-course untargeted isoniazid preventive therapy in South Africa: time to rethink policy? [Editorial]. (2012) (0)
Abstract 19, 13th International Workshop on HIV, Lisbon, Portugal (2009) (0)
New antiretrovirals : what is on the way? : main article (2005) (0)
NEW D RUGS New Targets and Novel Antiretrovirals (2005) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Robin Wood?

Robin Wood is affiliated with the following schools:

Robin Wood's Academic­Influence.com Rankings

Robin Wood's Degrees

Similar Degrees You Can Earn

Why Is Robin Wood Influential?

Robin Wood's Published Works

Published Works

What Schools Are Affiliated With Robin Wood?

Robin Wood's AcademicInfluence.com Rankings